Abstract:On the basis of biological activities of the ethyl acetate extracts of four Xenorhabdus sp., including Xenorhabdus nematophila FUM 220, Xenorhabdus nematophila FUM 221, Xenorhabdus bovienii FUM 222, and Xenorhabdus bovienii FUM 223, X. nematophila FUM 220 was preferentially selected to track the isolation of responsible compounds. Chemical study on the ethyl acetate extract of X. nematophila isolate FUM220 which is derived from the native nematode Steinernema carpocapsae (Rhabditida: Steinernematidae), was evaluated, and eleven compounds, including xenocoumacin II (1), xenortide-396 (2), xenortide A (3), xenortide-410 (4), xenortide-449 (5), xenematide A 663 (6), rhabdopeptide-574 (7), rhabdopeptide-588 (8), rhabdopeptide-687 (9), rhabdopeptide-701 (10), and nematophin-273 (11) were characterized. In this experimental study, we surveyed the antitumoral potential of bacterial extract and bacterial metabolites to treat human breast cancer (MCF-7), human lung cancer (A549), and murine Tumor (B16) cell lines. We observed that all samples were cytotoxic, but bacterial extracts of X. nematophila FUM 220 and X. bovienii FUM 223 showed higher toxicity on mentioned cell lines. Potent cytotoxic activity was found for compounds 6 and 11 with IC50 of 6.2 mu g/ml against human lung cancer A549 cell lines, too. These compounds showed moderated antibacterial activity against Xanthomonas oryzae pv. oryzae strain Xoo-IR42 (Xanthomonadales: Xanthomonadaceae) (MIC of 62.5 mu g/ml) and Staphylococcus aureus strain 1112 (Bacillales: Staphylococcaceae) (MIC of 100 mu g/ml). The bacterial extracts from X. bovienii FUM 222 showed strong inhibition of the growth of S. aureus strain 1112, by a minimal inhibitory concentration assay (MIC of 53.5 mu g/ml). Xenorhabdus genera produce metabolites with potent cytotoxic and antibacterial activity. Single compounds can be isolated, identified, and commercialized, but various species or strains may change their anticancer or antimicrobial potential. The present study brings new clues regarding the qualified of Xenorhabdus as future peptide sources for supplying natural bioactive compounds and challenge multidrug-resistant bacteria, treat cancer, and plant diseases.

Isolating,purifying and detecting of activity of secondary metabolitie produced by myxobacteria 93431

Screening of myxobacteria strains producing bioactive substances against breast cancer

Anti-Tumor Effect of Polysaccharides Isolated from Taraxacum Mongolicum Hand-Mazz on Mcf-7 Human Breast Cancer Cells

Isolation, Identification, and Biological Characterization of 6 Secondary Metabolites Extracted from Myxococcus Xanthus 095B06

Isolation and Identification of Mangrove Marine Bacteria and Analysis of Their Bioactive Products

Isolation of a strong antialgal Streptomyces strain and study on its antialgal activities

Cyclic Depsipeptides and Linear Peptides with Cytotoxic and Antiphytopathogenic Activities from Symbiotic Bacteria Ofxenorhabdus(enterobacteriales: Morganellaceae) Genus

Bioassay-Based Screening of Myxobacteria Producing Antitumor Secondary Metabolites

Purification,Elucidation and Activities Study of Cytosporone B

Studies on the Cytotoxic Constituents from Marine Actinomycete Micromonospora Sp.(m2dg17)

Isolation and identification of secondary metabolites from marine-derived actinomycete WBF16

Molecular identification and structural detection of anti-cancer compound from marine Streptomyces akiyoshiensis GRG 6 (KY457710) against MCF-7 breast cancer cells

Preliminary Study of Cytotoxic Metabolite Produced by Marine Actinomycete M313

Study on the Antifungal Activity of Intracellular Secondary Metabolic Products from Xenorhabdus Nematophilus

Isolation of Secondary Metabolites with Antimicrobial Activities from Bacillus amyloliquefaciens LWYZ003

[Anti-Tumor Compounds from Submerger Fermentation Products of a Paecilomyces Militaris Strain].

Identification and Evaluation of Bioactivity of Compounds from the Mushroom Pleurotus Nebrodensis (agaricomycetes) Against Breast Cancer

Identification and Fermentation Optimization of A Marine-Derived Streptomyces Griseorubens with Anti-Tumor Activity

A milbemycin compound isolated from Streptomyces Sp. FJS31-2 with cytotoxicity and reversal of cisplatin resistance activity in A549/DDP cells

Study on the secondary metabolites and their anti-tumor activity from mangroves fungi PJX-41

Isolation, Purification and Identification of Trichoderma harzianum and Preliminary Study on Activity of Fermentation Broth